Clinical Trial Update: Immunization Against Tumor Cells in Sezary Syndrome [Phase 2]

View source ↗

Summary

Status update indicates the completion of a Phase 2 clinical trial evaluating an immunization against tumor cells in Sézary syndrome (cutaneous T-cell lymphoma)…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous T-cell Lymphoma
• Sézary Syndrome

Snippet

Sponsor: University of Pittsburgh | Conditions: Cutaneous T-cell Lymphoma, Sezary Syndrome | Phase 2 | Status: COMPLETED